Skip to content

CONMED CNMD Contract with Customer, Liability

Contract with Customer, Liability at other companies

Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
IAR
Integra LifeSciencesIART
Globus Medical logo
Globus MedicalGMED
Haemonetics logo
HaemoneticsHAE
LivaNova logo
LivaNovaLIVN

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.07B-34.0%
Enterprise value$1.89B-23.5%
P/E19.4×+5.8×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's contract with customer, liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's contract with customer, liability?
CONMED (CNMD) reported contract with customer, liability of $23.41M in Q1 2026.
How has CONMED's contract with customer, liability changed year-over-year?
CONMED's contract with customer, liability increased by 16.7% year-over-year, from $20.06M to $23.41M.
What is the long-term trend for CONMED's contract with customer, liability?
Over 5 years (2020 to 2025), CONMED's contract with customer, liability has grown at a 10.0% compound annual growth rate (CAGR), from $13.67M to $21.97M.